Paul Hastings’ New York and London Offices Represent Fresnillo plc in Inaugural US$800M Senior Notes Offering

Paul Hastings LLP, a leading global law firm, announced today that it represented Fresnillo plc, the world’s largest silver miner and one of the world’s largest precious metals miners, in connection with its inaugural international issuance of debt securities. Fresnillo is a U.K. organized, FTSE 100 company, with operations primarily in Mexico. The five times oversubscribed offering involved the issuance of US$800 million of 5.500% Senior Notes due 2023 pursuant to Rule 144A and Regulation S. The underwriters involved were Citigroup, Deutsche Bank and J.P. Morgan.

More >>

Tags:  Paul Hastings, LLP | New York

Renowned Trial Lawyer John P. “Sean” Coffey Joins Kramer Levin Naftalis & Frankel in New York: The Former NY Attorney General Candidate Will Lead the Firm’s Complex Litigation Group

Kramer Levin Naftalis & Frankel LLP announced today that prominent trial lawyer John P. “Sean” Coffey will join the firm on December 1, 2013 as a partner in New York, where he will serve as the firm’s chair of complex litigation.

More >>

Tags:  Kramer Levin Naftalis & Frankel LLP | New York

Cravath – Level 3 Financing, Inc.’s High-Yield Senior Debt Offering

Cravath represented the initial purchasers, Citigroup, BofA Merrill Lynch, Morgan Stanley, Credit Suisse, Jefferies, and J.P. Morgan Securities, in connection with the US$640 million 144A/Reg. S high‑yield senior debt offering of Level 3 Financing, Inc., guaranteed by Level 3 Communications, Inc., a facilities‑based provider of a broad range of integrated communications systems. The transaction closed on November 14, 2013.

More >>

Tags:  Cravath, Swaine & Moore LLP | New York

Davis Polk Advises Shire on Its Acquisition of ViroPharma

Davis Polk is advising Shire plc in connection with its approximately $4.2 billion acquisition of ViroPharma Incorporated. The closing of the transaction is subject to customary conditions, including the tender of a majority of the outstanding ViroPharma shares and the receipt of regulatory clearances. Pending antitrust authority clearances, it is anticipated that the transaction will close in the last quarter of 2013, the first quarter of 2014 or as soon as possible thereafter.

More >>

Tags:  Davis Polk & Wardwell LLP | New York

Simpson Thacher Represents KKR in its Announced $1.6 Billion Acquisition of the Brickman Group

The Firm is representing Kohlberg Kravis Roberts & Co. L.P. in connection with its acquisition of The Brickman Group, Ltd. LLC (“Brickman”) for $1.6 billion from Leonard Green & Partners, L.P. and other shareholders. The investment is being made by KKR North American Fund XI and other funds and accounts managed by KKR. The transaction is subject to customary closing conditions and is expected to close by the end of 2013.

More >>

Tags:  Simpson Thacher & Bartlett LLP | New York